It has a built-in specialization mechanism, which includes the capability to restrict allowable specializations.

The second mechanism is a more gradual process of adaptive mutation, whereby the capability of the virus to bind to human cells increases during subsequent infections of humans.

This allows existing solutions that use an asynchronous endpoint integration mechanism to be augmented with our simple throttling capability.